296 related articles for article (PubMed ID: 20143497)
41. [Mycotic complications in hemoblastoses].
Karaev ZO; Barantsevich EP; Podgurskaia RA
Gematol Transfuziol; 1988 Mar; 33(3):45-9. PubMed ID: 3290043
[No Abstract] [Full Text] [Related]
42. The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
Shang ST; Lin JC; Ho SJ; Yang YS; Chang FY; Wang NC
J Microbiol Immunol Infect; 2010 Jun; 43(3):200-6. PubMed ID: 21291847
[TBL] [Abstract][Full Text] [Related]
43. [Diagnosis of invasive mycoses in neutropenic patients with systemic hematologic diseases].
Glasmacher A; Marklein G; Just-Nübling G; Leutner C; Ewig S
Dtsch Med Wochenschr; 1998 Feb; 123(6):157-60. PubMed ID: 9505955
[No Abstract] [Full Text] [Related]
44. Invasive fungal infection in children undergoing chemotherapy for cancer.
Yeh TC; Liu HC; Wang LY; Chen SH; Liang DC
Ann Trop Paediatr; 2007 Jun; 27(2):141-7. PubMed ID: 17565811
[TBL] [Abstract][Full Text] [Related]
45. The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents.
Andriole VT
J Antimicrob Chemother; 1999 Aug; 44(2):151-62. PubMed ID: 10473222
[TBL] [Abstract][Full Text] [Related]
46. Treatment of invasive fungal infections in high-risk haematological patients: what have we learnt in the past 10 years?
Vallejo C; Vázquez L; Cabrera Martín JR; Carreras E; García Rodríguez J; Ruiz Camps I; Fortún J; Mensa J; Barberán J
Rev Esp Quimioter; 2013 Dec; 26(4):378-86. PubMed ID: 24399355
[TBL] [Abstract][Full Text] [Related]
47. Treatment and timing in invasive mould disease.
Maertens J; Groll AH; Cordonnier C; de la Cámara R; Roilides E; Marchetti O
J Antimicrob Chemother; 2011 Jan; 66 Suppl 1():i37-43. PubMed ID: 21177402
[TBL] [Abstract][Full Text] [Related]
48. Invasive mycoses: diagnostic challenges.
Ostrosky-Zeichner L
Am J Med; 2012 Jan; 125(1 Suppl):S14-24. PubMed ID: 22196205
[TBL] [Abstract][Full Text] [Related]
49. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014.
Slavin MA; Thursky KA; Worth LJ; Chang CC; Morrissey CO; Blyth CC; Chen SC; Szer J
Intern Med J; 2014 Dec; 44(12b):1267-76. PubMed ID: 25482739
[TBL] [Abstract][Full Text] [Related]
50. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
Karthaus M; Böhme A
Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
[TBL] [Abstract][Full Text] [Related]
51. [Deep mycosis in patients with hematological diseases].
Yoshida M
Rinsho Ketsueki; 2008 Aug; 49(8):567-75. PubMed ID: 18800604
[No Abstract] [Full Text] [Related]
52. Management of infections in patients with acute leukemia.
Sarkodee-Adoo CB; Merz WG; Karp JE
Oncology (Williston Park); 2000 May; 14(5):659-66, 671-2; discussion 672-7. PubMed ID: 10853459
[TBL] [Abstract][Full Text] [Related]
53. [Clinical manifestation and treatment of blood disease combined with invasive fungal infection].
Shen ZX; Chen QS
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1447-8. PubMed ID: 16061018
[No Abstract] [Full Text] [Related]
54. Invasive fungal infections in onco-haematology: a Spanish perspective.
Rev Esp Quimioter; 2011 Sep; 24(3):168-72. PubMed ID: 21947102
[No Abstract] [Full Text] [Related]
55. [Prevention of fungal infections of endogenic origin].
Rovira M; Carreras E
Rev Esp Quimioter; 2004 Mar; 17(1):101-4. PubMed ID: 15201933
[No Abstract] [Full Text] [Related]
56. Invasive mycoses following trauma.
Hajdu S; Obradovic A; Presterl E; Vécsei V
Injury; 2009 May; 40(5):548-54. PubMed ID: 18656189
[TBL] [Abstract][Full Text] [Related]
57. Management of invasive fungal infections in neutropenic patients.
Akan H
Hematology; 2005; 10 Suppl 1():234-7. PubMed ID: 16188681
[No Abstract] [Full Text] [Related]
58. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
Kern WV; Beyer J; Böhme A; Buchheidt D; Cornely O; Einsele H; Kisro J; Krüger W; Maschmeyer G; Ruhnke M; Schmidt CA; Schwartz S; Szelenyi H;
Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1582-8. PubMed ID: 11199452
[No Abstract] [Full Text] [Related]
59. [Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Glasmacher A; Just-Nübling G; Molitor E
Dtsch Med Wochenschr; 1998 Feb; 123(7):191-4. PubMed ID: 9505945
[No Abstract] [Full Text] [Related]
60. Changing epidemiology of systemic fungal infections.
Richardson M; Lass-Flörl C
Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
